Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Answer: Behavioral isolation.
Mechanical isolation. ...
Temporal isolation
Global warming is heating up their environments and melting away their glacier habitat. If their home ever got completely rid of ice they'd die of a heat stroke.
What controls what molecules pass in and out of a cell?
Answer:
4778.4 cm³
Explanation:
The formulae of finding the volume of a cone = 1/3 * π * r² * h
(r = radius; h = height)
Therefore replacing the variable with values gives = 1/3 * π * 13² * 27
= 4,778.3624261100755157016805859681
Volume to the nearest tenth = 4778.4 cm³
